Literature DB >> 32396018

Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice.

Jorge R Georgakopoulos1, Ron Vender2,3, Jensen Yeung1,4,5,6.   

Abstract

Entities:  

Keywords:  COVID-19; apremilast; dermatology; psoriasis

Mesh：

Substances：

Year:  2020        PMID： 32396018     DOI： 10.1177/1203475420928382

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN： 1203-4754            Impact factor:   2.092


× No keyword cloud information.
  1 in total

1.  Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study.

Authors:  Y Lytvyn; J R Georgakopoulos; A Mufti; A R Devani; M J Gooderham; V Jain; P Lansang; R Vender; V H Prajapati; J Yeung
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-28       Impact factor: 9.228
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.